J. Safra Sarasin Holding AG lessened its position in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 70.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,864 shares of the technology company’s stock after selling 9,133 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Veeva Systems were worth $1,151,000 as of its most recent filing with the SEC.
Other large investors also recently added to or reduced their stakes in the company. ASR Vermogensbeheer N.V. grew its stake in Veeva Systems by 64.2% in the second quarter. ASR Vermogensbeheer N.V. now owns 5,167 shares of the technology company’s stock valued at $1,488,000 after purchasing an additional 2,020 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of Veeva Systems by 33.7% in the 3rd quarter. Nordea Investment Management AB now owns 523,247 shares of the technology company’s stock valued at $153,099,000 after acquiring an additional 131,974 shares in the last quarter. Compass Wealth Management LLC bought a new position in shares of Veeva Systems in the third quarter valued at approximately $18,694,000. Stevens Capital Management LP acquired a new stake in shares of Veeva Systems in the second quarter worth $306,000. Finally, Orser Capital Management LLC acquired a new stake in shares of Veeva Systems in the third quarter worth $1,631,000. 88.20% of the stock is owned by institutional investors and hedge funds.
Veeva Systems Price Performance
Shares of VEEV stock opened at $217.66 on Thursday. Veeva Systems Inc. has a one year low of $201.54 and a one year high of $310.50. The stock has a fifty day moving average price of $229.28 and a 200 day moving average price of $265.65. The stock has a market cap of $35.78 billion, a P/E ratio of 42.35, a price-to-earnings-growth ratio of 1.61 and a beta of 1.07.
Veeva Systems declared that its board has approved a stock buyback program on Monday, January 5th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the technology company to reacquire up to 5.5% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.
Wall Street Analyst Weigh In
VEEV has been the topic of several recent analyst reports. Weiss Ratings downgraded shares of Veeva Systems from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. KeyCorp reiterated a “sector weight” rating on shares of Veeva Systems in a report on Friday, December 12th. Truist Financial upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a research note on Thursday, January 8th. UBS Group dropped their target price on shares of Veeva Systems from $310.00 to $280.00 and set a “neutral” rating on the stock in a research report on Friday, November 21st. Finally, Canaccord Genuity Group reiterated a “buy” rating on shares of Veeva Systems in a research note on Tuesday, November 25th. Eighteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $308.04.
Get Our Latest Research Report on Veeva Systems
Insider Transactions at Veeva Systems
In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the completion of the transaction, the insider owned 23,204 shares in the company, valued at $5,370,101.72. This trade represents a 4.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.30% of the stock is owned by company insiders.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Further Reading
- Five stocks we like better than Veeva Systems
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
